Peptide Trainings

PT-141 vs Kisspeptin-10

Compare two distinct sexual-health research pathways.

PT-141

The only FDA-approved peptide for sexual dysfunction — works centrally in the brain

PT-141, now known as Bremelanotide (brand name Vyleesi), is an FDA-approved peptide for hypoactive sexual desire disorder (HSDD) in premenopausal women. Unlike PDE5 inhibitors (Viagra, Cialis) which work on blood flow, PT-141 works centrally in the brain through melanocortin receptors to increase sexual desire and arousal in both men and women.

Mechanism of action

PT-141 is a melanocortin receptor agonist, primarily acting on MC3R and MC4R in the hypothalamus and limbic system. These receptors are involved in regulating sexual arousal and desire pathways. By activating these central pathways, PT-141 increases sexual motivation and arousal independently of peripheral vascular effects.

Benefits discussed in research

  • FDA-approved for female sexual dysfunction (HSDD)
  • Increases sexual desire and arousal in both sexes
  • Works centrally in the brain — not dependent on blood flow
  • Effective for men with erectile dysfunction unresponsive to PDE5 inhibitors
  • Enhances sexual satisfaction and orgasm intensity
  • Works regardless of hormonal status

Research status

FDA Approved

Dosing information

For educational and research purposes only. Not medical advice.

typical
1.75 mg per dose (FDA-approved dose for women)
range
0.5–2 mg per dose
frequency
As needed, 45 minutes before sexual activity
route
Subcutaneous injection or intranasal
cycleLength
As needed (not for daily use)
notes
The FDA-approved dose for women is 1.75 mg subcutaneous injection. Men typically use 1–2 mg. Effects begin within 45 minutes and last 6–12 hours. Do not use more than once every 24 hours. Nausea is the most common side effect and can be reduced by starting with lower doses.

Side effects and safety

  • Nausea (most common, especially at higher doses)
  • Flushing and hot flashes
  • Headache
  • Transient blood pressure increase
  • Hyperpigmentation with repeated use

Frequently asked questions

Is PT-141 the same as Melanotan II?

They are related but different. PT-141 was actually developed from Melanotan II by removing the part that causes tanning. Researchers wanted the sexual function benefits without the skin-darkening effects. The result is PT-141, which is FDA-approved and specifically designed for sexual health. Melanotan II is not FDA-approved and still has the tanning effects.

Can men use PT-141?

Yes. The FDA approved it specifically for women, but the clinical research includes men too. It has shown results for men with erectile dysfunction who do not respond to Viagra or Cialis — which makes sense, because it works through a completely different pathway. Viagra works on blood flow. PT-141 works on the brain's desire and arousal centers. If the problem is desire rather than plumbing, PT-141 may be the better fit.

Research references

Read the PT-141 profile

Kisspeptin-10

A hypothalamic peptide that regulates reproductive hormones and sexual motivation

Kisspeptin-10 is the shortest active fragment of kisspeptin, a neuropeptide encoded by the KISS1 gene. It plays a critical role in regulating the hypothalamic-pituitary-gonadal (HPG) axis, which controls the production of LH, FSH, testosterone, and estrogen. It is being studied for fertility treatment, hypogonadism, and sexual function.

Mechanism of action

Kisspeptin-10 binds to the KISS1R receptor (GPR54) on GnRH neurons in the hypothalamus, triggering a pulsatile release of GnRH. This stimulates the pituitary to release LH and FSH, which in turn stimulate the gonads to produce testosterone (in men) and estrogen/progesterone (in women). This makes it a master regulator of the entire reproductive hormone cascade.

Benefits discussed in research

  • Stimulates LH and FSH release, boosting testosterone and estrogen
  • Improves sexual motivation and arousal
  • Potential treatment for hypogonadotropic hypogonadism
  • May improve fertility in both men and women
  • Regulates puberty and reproductive function
  • Being studied as an alternative to TRT for maintaining natural testosterone production

Research status

Phase II

Dosing information

For educational and research purposes only. Not medical advice.

typical
1–3 mcg/kg body weight per dose
range
0.5–10 mcg/kg per dose
frequency
Pulsatile dosing — every 90 minutes (mimics natural rhythm) or 1–2 times daily
route
Subcutaneous injection or intravenous (clinical)
cycleLength
Varies by indication — typically 4–8 weeks
notes
Pulsatile administration is critical — continuous infusion leads to receptor desensitization and paradoxical suppression of LH. For most users, 1–2 daily injections are practical. Research protocols often use 1 mcg/kg doses.

Side effects and safety

  • Mild flushing
  • Nausea (rare)
  • Receptor desensitization with continuous use
  • Generally well tolerated in clinical studies

Frequently asked questions

Can Kisspeptin-10 replace testosterone replacement therapy?

For some men, it might be a better option than TRT. Here is the key difference: TRT gives you testosterone from the outside, which tells your body to stop making its own. Over time, your testicles shrink and your fertility drops. Kisspeptin-10 works upstream — it tells your brain to signal your body to make more testosterone naturally. Your own production stays intact, and so does your fertility. It is being studied specifically for men who want the benefits of higher testosterone without losing the ability to have children.

Research references

Read the Kisspeptin-10 profile

More comparisons